Malay Glaucoma Eye Study II Navigation, Mobility and Reading Ability in Primary Glaucoma
MaGESII
Malay Glaucoma Eye Study II: Elucidating Navigation, Mobility and Reading Ability to Improve Quality of Life and Progression of Primary Glaucoma
2 other identifiers
interventional
300
1 country
1
Brief Summary
With the improvement of health system, the life span of Asians has increased tremendously especially in Malaysia. As an early preparation to be an 'aging country' in 2023, Malaysia needs to prepare infrastructure and policy to improve quality of life (QoL) in older adults. Glaucoma is an aging related chronic disease that cause progressive optic neuropathy and visual field defect1. The main aim of glaucoma treatment is to slow down disease progression and preserve patient's QoL2. Modification of intraocular (IOP) is believed to be the mainstay of treatment but may not prevent progression of the disease. Modification of lifestyle has been found to change the prognosis of many chronic diseases such as diabetes mellitus. However, there is minimal evidence on the effect of lifestyle modification on glaucoma. Although constricted visual field almost asymptomatic especially in primary open angle glaucoma but many domestic injuries such as fall has been reported. Glaucoma patients reported greatest restriction with mobility especially driving compared to the other domains3,4. Reduction of walking and moderate-to-vigorous physical activity was also found in those with bilateral visual field loss5. Progressive constriction of visual field has been found to increase dependency, reduce mobility, pleasure of reading and QoL of glaucoma patients6. This will lead to psychological and emotional disturbance, in certain cases even resulted in depression. On the other hand, being physically active is found to have some protective effect against development and severity of glaucoma8,9. Thus, identifying problems related to physical activities in constricted visual field is important for improvement of rehabilitation and exercise regime for glaucoma patients. An exercise regime must be effective without causing major changes to IOP, safe in patients with constricted visual field and sensitive to social culture of Malaysians. Addressing these issues will lessen dependency and promotes healthy living among older adults. Improvement in navigation perhaps may increase the physical activities in glaucoma. Reading is another important pleasure in life. Visual field defect in glaucoma patients has been reported to associate with slower reading speed, saccade rate and visual span10,11. Identification of factors associated with difficulty in reading among glaucoma patients and development of rehabilitation regime in reading may improve the happiness index in literate patients. Nevertheless, there is no specific rehabilitation program to improve reading abilities among glaucoma patients. A combination of visual rehabilitation of low vision therapy and occupational therapy is ideal. Although, there is improvement in reading ability and mobility post low visual aid rehabilitation but there is no evidence on glaucoma patients specifically12. Improvement in daily living and dependency may improve their QoL. Happiness perhaps may improve the balance between oxidative stress damage and antioxidant level. Many previous studies discovered that various biomarkers of oxidative stress are elevated in people with depression, and anxiety disorders13. Similarly, oxidative stress has been implicated in pathogenesis of glaucoma and accelerates retinal ganglion cell damage in glaucoma14. Indirectly, improvement of QoL will help in halting the progression of visual field defect. Based on the previous research project on Malays in Malaysia, navigation and mobility has been identified to be mostly affect in primary glaucoma patients based on QoL questionnaires. Physical activities have potential protective effect against progression and severity of glaucoma9. Improvement in navigation, physical activities and reading ability, perhaps may improve their QoL. The main problem is how do we improve their navigation, physical activities and reading ability despite their constricted visual field. The most important step is to understand the problem and issues pertaining to the navigation, physical activities and reading faced by patients with glaucoma.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2020
CompletedFirst Submitted
Initial submission to the registry
November 28, 2020
CompletedFirst Posted
Study publicly available on registry
February 3, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2024
CompletedFebruary 3, 2021
February 1, 2021
3.5 years
November 28, 2020
February 2, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (30)
Navigation: completion of maze
Time to complete the maze (minutes)
Baseline (before randomization)
Navigation: completion of maze
Time to complete the maze (minutes)
24 weeks after randomization
Navigation: number of obstacles
Number of stumbles and bumps while walking through the maze (number)
Baseline (before randomization)
Navigation: number of obstacles
Number of stumbles and bumps while walking through the maze (number)
24 weeks after randomization
Mobility at home
Accelerometer reading (steps/day)
Baseline (before randomization)
Mobility at home
Accelerometer reading (steps/day)
2 weeks after randomization
Mobility at home
Accelerometer reading (steps/day)
4 weeks after randomization
Mobility at home
Accelerometer reading (steps/day)
8 weeks after randomization
Mobility at home
Accelerometer reading (steps/day)
16 weeks after randomization
Mobility at home
Accelerometer reading (steps/day)
24 weeks after randomization
Physical activity and exercise
Accelerometer reading of moderate-vigorous physical activity (MVPA) (number)
Baseline (before randomization)
Physical activity and exercise
Accelerometer reading of moderate-vigorous physical activity (MVPA) (number)
2 weeks after randomization
Physical activity and exercise
Accelerometer reading of moderate-vigorous physical activity (MVPA) (number)
4 weeks after randomization
Physical activity and exercise
Accelerometer reading of moderate-vigorous physical activity (MVPA) (number)
8 weeks after randomization
Physical activity and exercise
Accelerometer reading of moderate-vigorous physical activity (MVPA) (number)
16 weeks after randomization
Physical activity and exercise
Accelerometer reading of moderate-vigorous physical activity (MVPA) (number)
24 weeks after randomization
Reading speed of near vision chart
Number of words per minute
Baseline (before randomization
Reading speed of near vision chart
Number of words per minute
24 weeks after randomization
Reading speed of the provided materials (prescription label and newspaper)
Number of words per minute
Baseline (before randomization)
Reading speed of the provided materials (prescription label and newspaper)
Number of words per minute
24 weeks after randomization
Reading speed of the given book
Number of pages per hour
Baseline (before randomization)
Reading speed of the given book
Number of pages per hour
8 weeks after randomization
Reading speed of the given book
Number of pages per hour
16 weeks after randomization
Reading speed of the given book
Number of pages per hour
24 weeks after randomization
Quality of life score
Total score from each domains of Bahasa Malaysia version of Glaucoma Quality of life 36 questionnaire (GlauQoL 36) using likert scoring 1-5
Baseline (before randomization)
Quality of life score
Total score from each domains of Bahasa Malaysia version of Glaucoma Quality of life 36 questionnaire (GlauQoL 36) using likert scoring 1-5
24 weeks after randomization
Depression score
Using Bahasa Malaysia version of geriatric depression scale 14 (MGDS 14) questionnaire. The score of 8 and above is considered as depressed.
Baseline (before randomization)
Depression score
Using Bahasa Malaysia version of geriatric depression scale 14 (MGDS 14) questionnaire. The score of 8 and above is considered as depressed.
24 weeks after randomization
Serum total anti-oxidant capacity (TAC)
The concentration of the TAC level (Ta) using a commercialized kit (QuantiChromTM Antioxidant Assay Kit (DTAC-100, BioAssay System, USA)
Baseline (before randomization)
Serum total anti-oxidant capacity (TAC)
The concentration of the TAC level (Ta) using a commercialized kit (QuantiChromTM Antioxidant Assay Kit (DTAC-100, BioAssay System, USA)
24 weeks after randomization
Secondary Outcomes (7)
Intraocular pressure (IOP)
Baseline (before randomization)
Intraocular pressure (IOP)
8 weeks after randomization
Intraocular pressure (IOP)
16 weeks after randomization
Intraocular pressure (IOP)
24 weeks after randomization
Retinal nerve fiber layer thickness (RNFL)
Baseline (before randomization)
- +2 more secondary outcomes
Study Arms (2)
Rehabilitation group
ACTIVE COMPARATORThis is the phase 3 of the entire research protocol. Phase 3 will be initiated once the phase 2 (development of rehabilitation module) is completed. A user friendly and inexpensive device and program with minimal usage of low vision aid will be designed and piloted. There are 3 different rehabilitation modules. A total of 300 primary glaucoma patients will be recruited and randomized using SNOSE: 150 intervention group and 150 non-intervention group. The intervention group will comprised of 150 primary glaucoma patients who will be assigned to different rehabilitation program: 1. navigation and mobility (50 patients) 2. physical activities including special exercise (50 patients) 3. reading (50 patients) There will be no patient who will be involved in more than one rehabilitation program at anytime.
Non-rehabilititation group
NO INTERVENTIONGroup of primary glaucoma patients who are not taught and practiced the new rehabilitation module for navigation, physical activity (exercise) and reading. They will be asked to continue their regular activities and provided with the similar reading material (book) to read daily.
Interventions
The visual rehabilitation regime consist of education and activity include dressing, feeding, personal hygiene and grooming activities, functional mobility, room orientation and memory, reading, eye hand coordination and also optokinetic training programme. A diary will be given to assess their compliance. Reassessment based on the number of fall, stumble etc when they go through a maze (developed in Phase 1)will be done every 2weeks for 8 weeks (4 times), every 4 weeks for next 8 weeks (2 times) and the final assessment 8 weeks later. A total study intervention will be 24 weeks
An instruction course will be conducted and a CD (with step by step exercise demonstration) will be given to the patients in group A. They will be asked to come for another session in 2 weeks. Then they will be asked to conduct the exercise for at least three times a week for 24 weeks. Exercise diary and accelerometer will also be given to patients of both groups. They will be seen in the clinic every 8 weeks.
Patient in intervention group will be asked to complete a reading task (reading the given book) a day, number of pages completed in an hour per day and time taken to complete a page in given book. They are asked to complete the books within 24 weeks with follow up every 8 weeks.
Eligibility Criteria
You may qualify if:
- Known cases of POAG and PACG who are compliance to treatment and follow up
- Those who have more than 10 degree from fixation (based on Humphrey visual field)
- Best corrected visual acuity of 6/60 on the better seeing eye
- Pseudophakic or phakic (without visually significant cataract)
You may not qualify if:
- History of surgical intervention 3 months prior to recruitment
- Physical disabilities such as stroke, limbs amputation
- Severe hearing impairment
- Those with macular and retinal pathology
- Those already on low vision aids
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Universiti Sains Malaysialead
- Ministry of Health, Malaysiacollaborator
- Universiti Teknologi Maracollaborator
Study Sites (1)
Universiti Sains Malaysia
Kota Bharu, Kelantan, 16150, Malaysia
Related Publications (19)
Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014 Nov;121(11):2081-90. doi: 10.1016/j.ophtha.2014.05.013. Epub 2014 Jun 26.
PMID: 24974815RESULTWeinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. JAMA. 2014 May 14;311(18):1901-11. doi: 10.1001/jama.2014.3192.
PMID: 24825645RESULTFriedman DS, Freeman E, Munoz B, Jampel HD, West SK. Glaucoma and mobility performance: the Salisbury Eye Evaluation Project. Ophthalmology. 2007 Dec;114(12):2232-7. doi: 10.1016/j.ophtha.2007.02.001. Epub 2007 Nov 5.
PMID: 17980433RESULTTurano KA, Rubin GS, Quigley HA. Mobility performance in glaucoma. Invest Ophthalmol Vis Sci. 1999 Nov;40(12):2803-9.
PMID: 10549639RESULTViswanathan AC, McNaught AI, Poinoosawmy D, Fontana L, Crabb DP, Fitzke FW, Hitchings RA. Severity and stability of glaucoma: patient perception compared with objective measurement. Arch Ophthalmol. 1999 Apr;117(4):450-4. doi: 10.1001/archopht.117.4.450.
PMID: 10206571RESULTIzzotti A, Bagnis A, Sacca SC. The role of oxidative stress in glaucoma. Mutat Res. 2006 Mar;612(2):105-14. doi: 10.1016/j.mrrev.2005.11.001. Epub 2006 Jan 18.
PMID: 16413223RESULTMajsterek I, Malinowska K, Stanczyk M, Kowalski M, Blaszczyk J, Kurowska AK, Kaminska A, Szaflik J, Szaflik JP. Evaluation of oxidative stress markers in pathogenesis of primary open-angle glaucoma. Exp Mol Pathol. 2011 Apr;90(2):231-7. doi: 10.1016/j.yexmp.2011.01.001. Epub 2011 Jan 15.
PMID: 21241689RESULTMarkowitz M. Occupational therapy interventions in low vision rehabilitation. Can J Ophthalmol. 2006 Jun;41(3):340-7. doi: 10.1139/I06-020.
PMID: 16767190RESULTMcKean-Cowdin R, Wang Y, Wu J, Azen SP, Varma R; Los Angeles Latino Eye Study Group. Impact of visual field loss on health-related quality of life in glaucoma: the Los Angeles Latino Eye Study. Ophthalmology. 2008 Jun;115(6):941-948.e1. doi: 10.1016/j.ophtha.2007.08.037. Epub 2007 Nov 12.
PMID: 17997485RESULTNilsson UL. Visual rehabilitation of patients with advanced stages of glaucoma, optic atrophy, myopia or retinitis pigmentosa. Doc Ophthalmol. 1988 Dec;70(4):363-83. doi: 10.1007/BF00157066.
PMID: 3266961RESULTChong Seong NT, Yaakub A, Jalil RA, Tirmandas Vn K, A/P Sandragasu T, Noor JBM, Husain NB, Mustari ZB, Hamid SAA, Mt Saad AB, At LS. Effect of physical activity on severity of primary angle closure glaucoma. Ther Adv Ophthalmol. 2019 Jul 29;11:2515841419864855. doi: 10.1177/2515841419864855. eCollection 2019 Jan-Dec.
PMID: 31384724RESULTRamulu PY, Maul E, Hochberg C, Chan ES, Ferrucci L, Friedman DS. Real-world assessment of physical activity in glaucoma using an accelerometer. Ophthalmology. 2012 Jun;119(6):1159-66. doi: 10.1016/j.ophtha.2012.01.013. Epub 2012 Mar 2.
PMID: 22386950RESULTRamulu P. Glaucoma and disability: which tasks are affected, and at what stage of disease? Curr Opin Ophthalmol. 2009 Mar;20(2):92-8. doi: 10.1097/ICU.0b013e32832401a9.
PMID: 19240541RESULTRamulu PY, West SK, Munoz B, Jampel HD, Friedman DS. Glaucoma and reading speed: the Salisbury Eye Evaluation project. Arch Ophthalmol. 2009 Jan;127(1):82-7. doi: 10.1001/archophthalmol.2008.523.
PMID: 19139345RESULTSacca SC, Izzotti A, Rossi P, Traverso C. Glaucomatous outflow pathway and oxidative stress. Exp Eye Res. 2007 Mar;84(3):389-99. doi: 10.1016/j.exer.2006.10.008. Epub 2006 Dec 29.
PMID: 17196589RESULTSalim S. Oxidative stress and psychological disorders. Curr Neuropharmacol. 2014 Mar;12(2):140-7. doi: 10.2174/1570159X11666131120230309.
PMID: 24669208RESULTStelmack JA, Tang XC, Wei Y, Wilcox DT, Morand T, Brahm K, Sayers S, Massof RW; LOVIT II Study Group. Outcomes of the Veterans Affairs Low Vision Intervention Trial II (LOVIT II): A Randomized Clinical Trial. JAMA Ophthalmol. 2017 Feb 1;135(2):96-104. doi: 10.1001/jamaophthalmol.2016.4742.
PMID: 27978569RESULTvan Landingham SW, Willis JR, Vitale S, Ramulu PY. Visual field loss and accelerometer-measured physical activity in the United States. Ophthalmology. 2012 Dec;119(12):2486-92. doi: 10.1016/j.ophtha.2012.06.034. Epub 2012 Aug 11.
PMID: 22892152RESULTWilkinson ME, Shahid KS. Low vision rehabilitation: An update. Saudi J Ophthalmol. 2018 Apr-Jun;32(2):134-138. doi: 10.1016/j.sjopt.2017.10.005. Epub 2017 Oct 27.
PMID: 29942183RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Liza Sharmini Ahmad Tajudin, Prof. Dr.
Department of Ophthalmology, School of Medical Sciences, Universiti Sains Malaysia
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, Head of Glaucoma Research, Principal Investigator
Study Record Dates
First Submitted
November 28, 2020
First Posted
February 3, 2021
Study Start
October 1, 2020
Primary Completion
March 31, 2024
Study Completion
March 31, 2024
Last Updated
February 3, 2021
Record last verified: 2021-02